A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines in Vitro
| dc.contributor.author | Uyuklu, Tolga | |
| dc.contributor.author | Ural, A. Uğur | |
| dc.contributor.author | Sarper, Metal | |
| dc.contributor.author | Avcu, Ferit | |
| dc.contributor.author | Baran, Yusuf | |
| dc.contributor.author | Elçi, Pınar | |
| dc.contributor.author | Akar, Nejat | |
| dc.coverage.doi | 10.1182/blood.V110.11.4183.4183 | |
| dc.date.accessioned | 2021-01-24T18:32:11Z | |
| dc.date.available | 2021-01-24T18:32:11Z | |
| dc.date.issued | 2007 | |
| dc.description | 49th Annual Meeting of the American-Society-of-Hematology | en_US |
| dc.description.abstract | The most important problem in the treatment of Multiple Myeloma (MM) is the multi drug resistance (MDR) observed before and after the treatment. For this reason in MM cases an early resistance to treatment can be developed or the disease can relapsed in early period. Yet, there has been no improved drug resistance against proteazom inhibitor Bortezomib (Bor), which is used alone or with other chemotherapeutic agents in resistant or relapsed MM cases | en_US |
| dc.description.sponsorship | American Society of Hematology | en_US |
| dc.identifier.doi | 10.1182/blood.V110.11.4183.4183 | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issn | 1528-0020 | |
| dc.identifier.uri | https://doi.org/10.1182/blood.V110.11.4183.4183 | |
| dc.identifier.uri | https://hdl.handle.net/11147/10072 | |
| dc.language.iso | en | en_US |
| dc.publisher | American Society of Hematology | en_US |
| dc.relation.ispartof | Blood | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | A Study of Multiple Drug Resistance Mechanisms Improved Against Bortezomib on Multiple Myeloma Cell Lines in Vitro | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Baran, Yusuf | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Molecular Biology and Genetics | en_US |
| gdc.description.endpage | 113B | en_US |
| gdc.description.issue | 11 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 113B | en_US |
| gdc.description.volume | 110 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W2571599828 | |
| gdc.identifier.wos | WOS:000251101100439 | |
| gdc.index.type | WoS | |
| gdc.oaire.accesstype | BRONZE | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.6419722E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 1.312404E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.31 | |
| gdc.opencitations.count | 1 | |
| gdc.plumx.mendeley | 2 | |
| gdc.wos.citedcount | 1 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7bb863bb-9384-4a07-9fbb-b9c1ab7634a3 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4013-8abe-a4dfe192da5e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S0006497118404351-main.pdf
- Size:
- 62.24 KB
- Format:
- Adobe Portable Document Format
- Description:
- Conference Object